Charts NXS, page-351

First 351 Last

Share
Profile

Follow
Stickshift

6,982 Posts.

1787

16/10/19

11:58

Post #: 40906949
Share

Originally posted by sabine: ↑

The story above makes the point that issues (if there are any ) due to the 3M partnership are contained.
There’s also mention of new developments, and the fact competitors’ products don’t tackle the issue of infection in the same way ...

These are comments that have already been comprehensively covered in the forum.
but the statement below is not something that has been much talked about?

“The biggest challenge for us is driving adoption by users, to start to implement a fundamental change in medical practice.”

... As I read it, George. Savvides is simply saying NextScience needs stronger marketing?

Implementing the fundamental change in medical practise he wants to achieve is not the kJ f of thing I expect traditionally comes about overnight - especially with hostile competitors protecting their interests.

....But in a world where things are constantly ‘going viral’ why take the traditional route?

Maybe for hospital-related sales it is necessary to operate through normal marketing channels - the trade shows etc but it sounds to me as if those arenas are controlled by the big entities, and the formula for successful selling is ‘who you know’ rather than what you can offer.

If NXS is is banging on the door of an essentially closed shop with the trade shows maybe it should be also using alternative marketing strategies on social media to inform the public direct ?

They are an incredibly professional team and no doubt already have this well in hand - ( they are possibly waiting on the launch of the acne products to start a campaign?), but currently I can’t even find the Facebook page nor an instagram account.

The Twitter page has a good update regards 3M actually doing some marketing (hopefully) for BlastX at a Las Vegas trade show that finished on Monday, but does not seem very oriented to marketing direct to the public.

Maybe I have the wrong end of the stick but I thought one of the best things about Blast X was that it’s like the perfect alternative to Dettol and to tree oil etc and you could put it on bandaids and possibly into soaps and supermarket trolley wipes and into aeroplanes and public toilets and everywhere else that ‘germ phobic’ civilised nations want to use it .....maybe even into mouthwash and toothpaste?

Cheers

Expand

Bacterial biofilms are most problematic where topical treatments (detoll, iodine etc) would be ineffective if applied; BlastX’s primary market is for use during surgery.

It sounds like a product with a lot of promise. Changing surgical behaviours to adopt this product is where the hard work currently is; over time the efficacy of the product should speak for itself.

NXS Price at posting: $2.81 Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 582 more messages in this thread...

First 351 Last

Add NXS (ASX) to my watchlist

(20min delay)
Last 38.0¢		Change 0.000(0.00%)		Mkt cap ! $110.8M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	72440	38.0¢

Sellers (Offers)

Price($)	Vol.	No.
40.0¢	56084	3

View Market Depth

No.	Vol.	Price($)
1	72440	0.380
1	2000	0.355
1	10000	0.350
1	14000	0.330
1	3076	0.325

Price($)	Vol.	No.
0.400	56084	3
0.415	10000	1
0.420	24189	1
0.430	26320	1
0.440	50942	2

Last trade - 07.00am 15/05/2024 (20 minute delay)

NXS (ASX) Chart

Day chart unavailable

Charts NXS, page-351

Featured News

D3E joins ASX as it hunts natural gas and helium in South Africa

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Magnum to raise US$210M to advance Saudi green pig iron plant

BHP fails to secure second takeover offer to Anglo American

Meet Sun Silver – ASX's newest silver-gold player based in Nevada, USA

Buyers (Bids)

Sellers (Offers)

Featured News

Charts NXS, page-351

Featured News

Top Stories

D3E joins ASX as it hunts natural gas and helium in South Africa

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Magnum to raise US$210M to advance Saudi green pig iron plant

BHP fails to secure second takeover offer to Anglo American

Meet Sun Silver – ASX's newest silver-gold player based in Nevada, USA

Buyers (Bids)

Sellers (Offers)

Featured News